ProfileGDS4814 / ILMN_2227968
TitleOvarian cancer xenograft tumor response to trastuzumab and pertuzumab
OrganismHomo sapiens


none trastuzumab pertuzumab trastuzumab and pertuzumab GSM780707 GSM780708 GSM780709 GSM780719 GSM780720 GSM780721 GSM780710 GSM780711 GSM780712 GSM780722 GSM780723 GSM780724 GSM780713 GSM780714 GSM780715 GSM780725 GSM780726 GSM780727 GSM780716 GSM780717 GSM780718 GSM780728 GSM780729 86% 87% 87% 86% 88% 86% 87% 87% 87% 86% 88% 88% 88% 86% 87% 89% 87% 87% 89% 87% 88% 88% 86% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM780707Untreated after 4 days (C1_1)254.70386
GSM780708Untreated after 4 days (C2_1)277.37387
GSM780709Untreated after 4 days (C3_1)296.52487
GSM780719Untreated after 4 days (C1_2)261.09186
GSM780720Untreated after 4 days (C2_2)305.5888
GSM780721Untreated after 4 days (C3_2)268.93786
GSM780710Trastuzumab treated after 4 days (T1_1)274.50887
GSM780711Trastuzumab treated after 4 days (T2_1)280.30387
GSM780712Trastuzumab treated after 4 days (T3_1)277.96987
GSM780722Trastuzumab treated after 4 days (T1_2)251.28886
GSM780723Trastuzumab treated after 4 days (T2_2)330.85988
GSM780724Trastuzumab treated after 4 days (T3_2)327.55688
GSM780713Pertuzumab treated after 4 days (P1_1)324.63688
GSM780714Pertuzumab treated after 4 days (P2_1)250.05486
GSM780715Pertuzumab treated after 4 days (P3_1)275.21987
GSM780725Pertuzumab treated after 4 days (P1_2)344.00789
GSM780726Pertuzumab treated after 4 days (P2_2)296.13687
GSM780727Pertuzumab treated after 4 days (P3_2)280.40187
GSM780716Trastuzumab and Pertuzumab treated after 4 days (TP1_1)351.62289
GSM780717Trastuzumab and Pertuzumab treated after 4 days (TP2_1)282.58987
GSM780718Trastuzumab and Pertuzumab treated after 4 days (TP3_1)312.13188
GSM780728Trastuzumab and Pertuzumab treated after 4 days (TP1_2)317.22388
GSM780729Trastuzumab and Pertuzumab treated after 4 days (TP2_2)257.886